- Home
- AXSM vs SEIC Comparison
AXSM vs SEIC Comparison
Compare AXSM & SEIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AXSM | SEIC |
|---|---|---|
| Founded | 2012 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.0B | 9.8B |
| IPO Year | 2015 | 1995 |
Fundamental Metrics
Financial Performance| Metric | AXSM | SEIC |
|---|---|---|
| Price | $164.42 | $80.29 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 17 | 7 |
| Target Price | ★ $209.18 | $106.00 |
| AVG Volume (30 Days) | 479.0K | ★ 767.9K |
| Earning Date | 05-18-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 1.28% |
| EPS Growth | ★ 38.56 | 27.66 |
| EPS | N/A | ★ 5.63 |
| Revenue | N/A | ★ $2,297,381,000.00 |
| Revenue This Year | $58.34 | $16.09 |
| Revenue Next Year | $54.30 | $7.31 |
| P/E Ratio | ★ N/A | $14.42 |
| Revenue Growth | N/A | ★ 8.10 |
| 52 Week Low | $86.99 | $64.66 |
| 52 Week High | $191.50 | $93.96 |
Technical Indicators
Market Signals| Indicator | AXSM | SEIC |
|---|---|---|
| Relative Strength Index (RSI) | 41.46 | 44.54 |
| Support Level | $148.14 | $77.91 |
| Resistance Level | $191.13 | $85.44 |
| Average True Range (ATR) | 5.38 | 2.21 |
| MACD | -1.07 | 0.02 |
| Stochastic Oscillator | 27.82 | 34.80 |
Price Performance
Historical ComparisonAbout AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About SEIC SEI Investments Company
SEI Investments provides investment processing, management, and operations services to financial institutions, asset managers, asset owners, and financial advisors in four material segments: private banks, investment advisors, institutional investors, and investment managers. SEI also has a minority interest in LSV Asset Management, a value equity asset manager with about $87 billion in assets under management. As of December 2024, SEI (including LSV) manages, administers, or advises about $1.6 trillion in assets.